Strontium ranelate: an effective solution for diverse fracture risks.

Abstract excerpt

Osteoporosis is listed by the WHO among the ten most frequent and socio-economically important, chronic diseases of mankind. The term osteoporosis however comprises a number of different pathophysiological conditions and clinical situations of weakened bones with increased risk of fragility fractures. A modern anti-osteoporotic drug should provide qualified study results proving therapeutic efficacy over this...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Body Mass Index
• Share to Bone Density Conservation Agents